382 related articles for article (PubMed ID: 8621443)
1. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
Soker S; Fidder H; Neufeld G; Klagsbrun M
J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
[TBL] [Abstract][Full Text] [Related]
2. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165.
Soker S; Gollamudi-Payne S; Fidder H; Charmahelli H; Klagsbrun M
J Biol Chem; 1997 Dec; 272(50):31582-8. PubMed ID: 9395496
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
[TBL] [Abstract][Full Text] [Related]
5. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
[TBL] [Abstract][Full Text] [Related]
6. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
Tessler S; Rockwell P; Hicklin D; Cohen T; Levi BZ; Witte L; Lemischka IR; Neufeld G
J Biol Chem; 1994 Apr; 269(17):12456-61. PubMed ID: 8175651
[TBL] [Abstract][Full Text] [Related]
7. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
[TBL] [Abstract][Full Text] [Related]
8. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Park JE; Chen HH; Winer J; Houck KA; Ferrara N
J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
[TBL] [Abstract][Full Text] [Related]
9. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
[TBL] [Abstract][Full Text] [Related]
10. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
[TBL] [Abstract][Full Text] [Related]
11. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
Soker S; Miao HQ; Nomi M; Takashima S; Klagsbrun M
J Cell Biochem; 2002; 85(2):357-68. PubMed ID: 11948691
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
Soker S; Takashima S; Miao HQ; Neufeld G; Klagsbrun M
Cell; 1998 Mar; 92(6):735-45. PubMed ID: 9529250
[TBL] [Abstract][Full Text] [Related]
13. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
[TBL] [Abstract][Full Text] [Related]
14. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
15. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
[TBL] [Abstract][Full Text] [Related]
16. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain.
Ruckman J; Green LS; Beeson J; Waugh S; Gillette WL; Henninger DD; Claesson-Welsh L; Janjić N
J Biol Chem; 1998 Aug; 273(32):20556-67. PubMed ID: 9685413
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
[TBL] [Abstract][Full Text] [Related]
18. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
Chou MT; Wang J; Fujita DJ
BMC Biochem; 2002 Dec; 3():32. PubMed ID: 12509223
[TBL] [Abstract][Full Text] [Related]
19. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.
Gitay-Goren H; Soker S; Vlodavsky I; Neufeld G
J Biol Chem; 1992 Mar; 267(9):6093-8. PubMed ID: 1556117
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
